ArticleWorld journal of surgical oncology2022

TET1 mutations as a predictive biomarker for immune checkpoint inhibitors in colon adenocarcinoma.

Tianzhu Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.